AD-212-A

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-212-A, covering 2024-08-01 to 2024-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121 [Phase 1]